The association of 83 plasma proteins with CHD mortality, BMI, HDL-, and total-cholesterol in men: Applying multivariate statistics to identify proteins with prognostic value and biological relevance

Journal of Proteome Research

Volumn 8, Issue 6, 2009, Pages 2640-2649

  Geert Heidema, A ^a,b,c   Thissen, Uwe ^d,e   Boer, Jolanda M A ^b   Bouwman, Freek G ^a   Feskens, Edith J M ^c   Mariman, Edwin C M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d TNO   (Netherlands)

^e TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

Author keywords

BMI; CHD; HDL cholesterol; Partial least squares; Proteomics

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CD40 ANTIGEN; CHOLESTEROL; FIBRINOGEN; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN M; INSULIN; LEPTIN; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MATRIX METALLOPROTEINASE; PLASMA PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD CLOTTING; BODY MASS; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FOLLOW UP; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; INFLAMMATION; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NETHERLANDS; PARTIAL LEAST SQUARES REGRESSION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEOMICS; RISK FACTOR; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS;

BIOLOGICAL MARKERS; BLOOD PROTEINS; BODY MASS INDEX; CHOLESTEROL; CORONARY DISEASE; HUMANS; LEAST-SQUARES ANALYSIS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; STATISTICS, NONPARAMETRIC;

EID: 67049110243     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr8006182     Document Type: Article

References (73)

1. Jain, K. S.; Kathiravan, M. K.; Somani, R. S.; Shishoo, C. J. The biology and chemistry of hyperlipidemia. Bioorg. Med. Chem. 2007, 15 (14), 4674-4699.
2. Bogers, R. P.; Bemelmans, W. J.; Hoogenveen, R. T.; Boshuizen, H. C.; Woodward, M.; Knekt, P.; van Dam, R. M.; Hu, F. B.; Visscher, T. L.; Menotti, A.; Thorpe, R. J., Jr.; Jamrozik, K.; Calling, S.; Strand, B. H.; Shipley, M. J. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch. Intern. Med. 2007, 167 (16), 1720-1728.
3. Link, J. J.; Rohatgi, A.; de Lemos, J. A. HDL cholesterol: physiology, pathophysiology, and management. Curr. Probl. Cardiol. 2007, 32 (5), 268-314.
4. Boulesteix, A. L.; Strimmer, K. Partial least squares: a versatile tool for the analysis of high-dimensional genomic data. Briefings Bioinf. 2007, 8 (1), 32-44. (Pubitemid 46157928)
5. Jackson, J. E. A User'S Guide to Principal Components, First ed.; Wiley - Interscience: New York, 1991.
6. Verschuren WMM, V. L. E.; Blokstra, A.; Seidell, J. C.; Smit, H. A.; Bueno de Mesquita, H. B.; Obermann-de Boer, G. L.; Kromhout, D. Cardiovascular disease risk factors in The Netherlands. Neth. J. Cardiol. 1993, 6, 205-210.
7. Kattermann, R.; Jaworek, D.; Möller, G.; Assmann, G.; Björkhem, I.; Svensson, L.; Borner, K.; Boerma, G.; Leijnse, B.; Desager, J. P.; Harwent, C.; Kupke, I.; Trinder, P. Multicentre study of a new enzymatic method of cholesterol determination. J. Clin. Chem. Clin. Biochem. 1984, 22, 245-251.
8. Lopes-Virella, M. F.; Stone, P.; Ellis, S.; Colwell, J. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin. Chem. 1977, 23, 882-884.
9. van den Berg, R. A.; Hoefsloot, H. C.; Westerhuis, J. A.; Smilde, A. K.; van der Werf, M. J. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 2006, 7, 142.
10. Smit, S.; van Breemen, M. J.; Hoefsloot, H. C.; Smilde, A. K.; Aerts, J. M.; de Koster, C. G. Assessing the statistical validity of proteomics based biomarkers. Anal. Chim. Acta 2007, 592 (2), 210-217.
11. Stone, M. Cross-validatory choice and assessment of statistical predictions. J. R. Stat. Soc., Ser. B 1974, 36 (2), 111-147.
12. Golland, P.; Liang, P.; Mukherjee, S.; Panchenko, D. Permutation tests of classification. Lect. Notes Comput. Sci. 2005, 3559, 501-515.
13. Mielke, P. W., Jr.; Berry, H. Permutation Methods: A Distance Function Approach; Springer: New York, 2001.
14. Faber, N. M. Uncertainty estimation for multivariate regression coefficients. Chemom. Intell. Lab. Syst. 2002, 64 (2), 169-179.
15. Thompson, A.; Danesh, J.; Associations between apolipoprotein, B.; apolipoprotein, A. I. The apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J. Intern. Med. 2006, 259 (5), 481-492.
16. de Ferranti, S. D.; Rifai, N. C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc. Pathol. 2007, 16 (1), 14-21.
17. Galkina, E.; Ley, K. Vascular adhesion molecules in atherosclerosis. Arterioscler., Thromb., Vasc. Biol. 2007, 27 (11), 2292-2301
18. Eaton, C. B.; Gramling, R.; Parker, D. R.; Roberts, M. B.; Lu, B.; Ridker, P. M. Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in Southeastern New England. Atherosclerosis 2008, 200 (1), 221-227.
19. Khurana, R.; Simons, M.; Martin, J. F.; Zachary, I. C. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation 2005, 112 (12), 1813-1824. (Pubitemid 41368158)
20. Considine, R. V.; Sinha, M. K.; Heiman, M. L.; Kriauciunas, A.; Stephens, T. W.; Nyce, M. R.; Ohannesian, J. P.; Marco, C. C.; McKee, L. J.; Bauer, T. L.; et al. , Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 1996, 334 (5), 292-295.
21. Jungner, I.; Walldius, G.; Holme, I.; Kolar, W.; Steiner, E. Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females. Int. J. Clin. Lab. Res. 1992, 21 (3), 247-255.
22. Dullens, S. P.; Plat, J.; Mensink, R. P. Increasing apoA-I production as a target for CHD risk reduction. Nutr. Metab. Cardiovasc. Dis. 2007, 17 (8), 616-628.
23. Blasi, C. The autoimmune origin of atherosclerosis. Atherosclerosis 2008, 201 (1), 17-32.
24. Packard, R. R.; Libby, P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin. Chem. 2008, 54 (1), 24-38.
25. Ross, R. Atherosclerosissan inflammatory disease. N. Engl. J. Med. 1999, 340 (2), 115-126.
26. Nishida, M.; Funahashi, T.; Shimomura, I. Pathophysiological significance of adiponectin. Med. Mol. Morphol. 2007, 40 (2), 55-67.
27. Arita, Y.; Kihara, S.; Ouchi, N.; Takahashi, M.; Maeda, K.; Miyagawa, J.; Hotta, K.; Shimomura, I.; Nakamura, T.; Miyaoka, K.; Kuriyama, H.; Nishida, M.; Yamashita, S.; Okubo, K.; Matsubara, K.; Muraguchi, M.; Ohmoto, Y.; Funahashi, T.; Matsuzawa, Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999, 257 (1), 79-83.
28. Trujillo, M. E.; Scherer, P. E. Adiponectinsjourney from an adipocyte secretory protein to biomarker of the metabolic syndrome. J. Intern. Med. 2005, 257 (2), 167-175.
29. Brummer, R. J. Effects of growth hormone treatment on visceral adipose tissue. Growth Horm. IGF Res. 1998, 8 (Suppl. B), 19-23.
30. Attallah, H.; Friedlander, A. L.; Hoffman, A. R. Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy. Growth Horm. IGF Res. 2006, 16 (Suppl. A), S62-67.
31. Moller, N.; Gjedsted, J.; Gormsen, L.; Fuglsang, J.; Djurhuus, C. Effects of growth hormone on lipid metabolism in humans. Growth Horm. IGF Res. 2003, 13 (Suppl. A), S18-21.
32. Luque, R. M.; Kineman, R. D. Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function. Endocrinology 2006, 147 (6), 2754-2763. (Pubitemid 43764612)
33. Abdu, T. A.; Neary, R.; Elhadd, T. A.; Akber, M.; Clayton, R. N. Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. Clin. Endocrinol. 2001, 55 (2), 209-216.
34. Key, T. J.; Allen, N. E.; Verkasalo, P. K.; Banks, E. Energy balance and cancer: the role of sex hormones. Proc. Nutr. Soc. 2001, 60 (1), 81-89.
35. Pasquali, R.; Casimirri, F.; De Iasio, R.; Mesini, P.; Boschi, S.; Chierici, R.; Flamia, R.; Biscotti, M.; Vicennati, V. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J. Clin. Endocrinol. Metab. 1995, 80 (2), 654-658.
36. Hernandez-Mijares, A.; Jarabo-Bueno, M. M.; Lopez-Ruiz, A.; Sola- Izquierdo, E.; Morillas-Arino, C.; Martinez-Triguero, M. L. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors. Int. J. Obes. 2007, 31 (6), 927-932.
37. Muscari, A.; Massarelli, G.; Bastagli, L.; Poggiopollini, G.; Tomassetti, V.; Drago, G.; Martignani, C.; Pacilli, P.; Boni, P.; Puddu, P. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur. Heart J. 2000, 21 (13), 1081-1090.
38. Mendez-Sanchez, N.; Gonzalez, V.; King-Martinez, A. C.; Sanchez, H.; Uribe, M. Plasma leptin and the cholesterol saturation of bile are correlated in obese women after weight loss. J. Nutr. 2002, 132 (8), 2195-2198. (Pubitemid 34851649)
39. Sniderman, A. D.; Faraj, M. Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome. Curr. Opin. Lipidol. 2007, 18 (6), 633-637.
40. Ylitalo, K.; Pajukanta, P.; Meri, S.; Cantor, R. M.; Mero-Matikainen, N.; Vakkilainen, J.; Nuotio, I.; Taskinen, M. R. Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia. Arterioscler., Thromb., Vasc. Biol. 2001, 21 (5), 838-843.
41. Leino, A.; Impivaara, O.; Kaitsaari, M.; Jarvisalo, J. Serum concentrations of apolipoprotein A-I, apolipoprotein B, and lipoprotein(a) in a population sample. Clin. Chem. 1995, 41 (11), 1633-1636.
42. Tobias, R. D. An Introduction to Partial Least Squares Regression; SAS Institute: Cary, NC, 1997.
43. Peduzzi, P.; Concato, J.; Kemper, E.; Holford, T. R.; Feinstein, A. R. A simulation study of the number of events per variable in logistic regression analysis. J. Clin. Epidemiol. 1996, 49 (12), 1373-1379.
44. Barrett, A. J.; Starkey, P. M. The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem. J. 1973, 133 (4), 709-724.
45. Gonzalez, P.; Alvarez, R.; Reguero, J. R.; Batalla, A.; Alvarez, V.; Cortina, A.; Cubero, G. I.; Garcia-Castro, M.; Coto, E. Variation in the lipoprotein receptor-related protein, alpha2-macroglobulin and lipoprotein receptor-associated protein genes in relation to plasma lipid levels and risk of early myocardial infarction. Coron. Artery Dis. 2002, 13 (5), 251-254.
46. Mocchegiani, E.; Costarelli, L.; Giacconi, R.; Cipriano, C.; Muti, E.; Malavolta, M. Zinc-binding proteins (metallothionein and alpha-2 macroglobulin) and immunosenescence. Exp. Gerontol. 2006, 41 (11), 1094-1107.
47. Shinkai, S.; Chaves, P. H.; Fujiwara, Y.; Watanabe, S.; Shibata, H.; Yoshida, H.; Suzuki, T. Beta2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein. Arch. Intern. Med. 2008, 168 (2), 200-206.
48. Wilson, A. M.; Kimura, E.; Harada, R. K.; Nair, N.; Narasimhan, B.; Meng, X. Y.; Zhang, F.; Beck, K. R.; Olin, J. W.; Fung, E. T.; Cooke, J. P. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation 2007, 116 (12), 1396-1403. (Pubitemid 47417566)
49. Saijo, Y.; Utsugi, M.; Yoshioka, E.; Horikawa, N.; Sato, T.; Gong, Y.; Kishi, R. Relationship of beta2-microglobulin to arterial stiffness in Japanese subjects. Hypertens. Res. 2005, 28 (6), 505-511.
50. Granger, D. N.; Vowinkel, T.; Petnehazy, T. Modulation of the inflammatory response in cardiovascular disease. Hypertension 2004, 43 (5), 924-931. (Pubitemid 38579889)
51. Lutgens, E.; Lievens, D.; Beckers, L.; Donners, M.; Daemen, M. CD40 and its ligand in atherosclerosis. Trends Cardiovasc. Med. 2007, 17 (4), 118-123.
52. Kannel, W. B. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 2005, 40 (12), 1215-1220. (Pubitemid 43117845)
53. Arend, W. P.; Malyak, M.; Guthridge, C. J.; Gabay, C. Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 1998, 16, 27-55.
54. Tedgui, A.; Mallat, Z. Anti-inflammatory mechanisms in the vascular wall. Circ. Res. 2001, 88 (9), 877-887.
55. Matsuura, E.; Kobayashi, K.; Tabuchi, M.; Lopez, L. R. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog. Lipid Res. 2006, 45 (6), 466-486.
56. Gear, A. R.; Camerini, D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 2003, 10 (3-4), 335-350. (Pubitemid 39004260)
57. Frangogiannis, N. G. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm. Res. 2004, 53 (11), 585-595.
58. Liehn, E. A.; Zernecke, A.; Postea, O.; Weber, C. Chemokines: inflammatory mediators of atherosclerosis. Arch. Physiol. Biochem. 2006, 112 (4-5), 229-238.
59. Thorn, E. M.; Khan, I. A. Pregnancy-associated plasma protein-A: an emerging cardiac biomarker. Int. J. Cardiol. 2007, 117 (3), 370-372.
60. Heeschen, C.; Dimmeler, S.; Hamm, C. W.; Fichtlscherer, S.; Simoons, M. L.; Zeiher, A. M. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J. Am. Coll. Cardiol. 2005, 45 (2), 229-237.
61. Bayes-Genis, A.; Conover, C. A.; Overgaard, M. T.; Bailey, K. R.; Christiansen, M.; Holmes, D. R., Jr.; Virmani, R.; Oxvig, C.; Schwartz, R. S. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N. Engl. J. Med. 2001, 345 (14), 1022-1029.
62. Shai, I.; Schulze, M. B.; Manson, J. E.; Rexrode, K. M.; Stampfer, M. J.; Mantzoros, C.; Hu, F. B. A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care 2005, 28 (6), 1376-1382. (Pubitemid 40756700)
63. Porsch-Oezcueruemez, M.; Kunz, D.; Kloer, H. U.; Luley, C. Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease. J. Am. Coll. Cardiol. 1999, 34 (7), 1995-2001.
64. Huang, J.; Brannan, D.; Sattler, L.; Alderman, J.; Lane, B.; O'Mathuna, C. A comparison of calibration methods based on calibration data size and robustness. Chemom. Intell. Lab. Syst. 2002, 62, 25-35.
65. Frank, I. E.; Friedman, J. H. A statistical view of some chemometrics regression tools. Technometrics 1993, 35, 109-135.
66. Hendriks, M. M. W. B.; Smit, S.; Akkermans, W. L. M. W.; Reijmers, T. H.; Eilers, P. H. C.; Hoefsloot, H. C. J.; Rubingh, C. M.; De Koster, C. G.; Aerts, J. M.; Smilde, A. K. How to distinguish healthy from diseased? Classification strategy for mass spectrometry-based clinical proteomics. Proteomics 2007, 7, 3672-3680. (Pubitemid 350022273)
67. Mertens, B. Organizing a competition on clinical mass spectrometry based proteomic diagnosis. Stat. Appl. Genet. Mol. Biol. 2008, 7 (2), Article 3.
68. Guyon, I.; Elisseeff, A. An introduction to variable and feature selection. J. Machine Learn. Res. 2003, 3, 1157-1182.
69. Feature Extraction, Foundations and Applications. Series: Studies in Fuzziness and Soft Computing; Guyon, I.; Gunn, S.; Nikravesh, M.; Zadeh, L., Eds.; Physica-Verlag, Springer: Berlin, 2006.
70. Martens, H.; Naes, T. Multivariate Calibration; Wiley: Chichester, 1989.
71. Leardi, R.; Boggua, R.; Terrile, M. Genetic algorithms as strategy for feature selection. J. Chemom. 1992, 6, 267-281.
72. Tibshirani, R. Regression shrinkage and selection via the lasso. J. R. Stat. Soc., Ser. B 1996, 58, 267-288.
73. Zhou, H.; Hastie, T. Regularization and variable selection via the elastic net. J. R. Stat. Soc., Ser. B 2005, 67, 301-320. (Pubitemid 40465877)